Myasthenia: Understanding Muscle Weakness, Causes, and Types

Myasthenia (Greek: muscle weakness) is a neuromuscular disorder characterized by fluctuating, fatigable weakness of skeletal muscles.

Pathophysiology: Autoantibodies (most commonly against acetylcholine receptors, AChR) impair neuromuscular junction transmission. Fewer functional receptors → reduced end-plate potentials → failure of muscle contraction.

Key Features

  • Weakness worsens with activity, improves with rest.
  • Ocular muscles often affected first (ptosis, diplopia).
  • Can generalize to bulbar (speech, swallowing), limb, respiratory muscles.
  • Myasthenic crisis = respiratory failure requiring ventilation.

Types

  • Autoimmune myasthenia gravis (AChR+, MuSK+, LRP4+, seronegative).
  • Congenital myasthenic syndromes (genetic, not immune-mediated).

Treatment

  • Acetylcholinesterase inhibitors (pyridostigmine).
  • Immunosuppression (steroids, azathioprine, mycophenolate, rituximab).
  • Thymectomy (for thymoma or generalized AChR+ MG).
  • Plasma exchange/IVIG for exacerbations.

Early diagnosis by a neurologist improves outcomes.

Muscle Strains - Related Articles